Biomart Global Technology Transfer

Country/Region: United States     State/Province: Columbia

Main Products: Chitosan, Chitin, Glucosamine

Company Introduction
BIOMART represent client universities and small businesses who are translating their new life sciences technologies into products for bio-pharmaceuticals, medical devices, clinical diagnostics, agriculture, aquaculture, chemicals, and, at times, other industries. BIOMART evaluates new techs and products for commercial viability; advises on commercialization and marketing strategy; and finds strategic partners and licensees.The biggest market for these techs tend to be in healthcare.Currently, we have offices in USA and England.
Company Overview

Business Type: Manufacturer, Buying House

Year Established: 2007

Employees: 501 - 1000 People

Plant Area: 3,000-5,000 square meters

Business Information

Main Markets: South America 12% Africa 8% Eastern Asia 10% Domestic Market 12% North America 8% Eastern Europe 10% Southern Europe 8% Mid East 10% Northern Europe 10% Oceania 12%

Trade Capacity: FOB, CFR, DDU

Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered

Nearest Port: United States

Trade & Financial Information

Annual Revenue: US$10 Million - US$50 Million

Total Revenue: US$50 Million - US$100 Million

Export Revenue: US$1 Million - US$2.5 Million

Annual Output: Below US$1 Million

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 91% - 100%

Payment Modes: USD, CAD, CNY

Lead Time: 7 days

Import/Export Mode: Corporation Limited Liability Company

Product Showcase
Chitosan
Chitin
Glucosamine

CL-Link > Health & Medicines in United States Health & Medicines in Columbia Medicines in United States Medicines in Columbia Chitosan in United States Chitosan in Columbia